Estramustine-binding protein (EMBP) content in four different cell lines and its correlation to estramustine induced metaphase arrest

Anticancer Research

Volumn 16, Issue 4 A, 1996, Pages 1819-1822

  Eklöv, Solveig ^a   Mahdy, Ensaf ^a   Wester, Kenneth ^a   Björk, Per ^b   Malmström, Per Uno ^a   Busch, Christer ^a   Nilsson, Sten ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Pharmacia & Upjohn AB   (Sweden)

Author keywords

Anti microtubule agent; Carcinoma cells; Cell lines; Estramustine; Estramustine binding protein; Metaphase

Indexed keywords

DRUG BINDING PROTEIN; ESTRAMUSTINE; MICROTUBULE ASSOCIATED PROTEIN; SECRETORY PROTEIN; TUBULIN;

ARTICLE; BLADDER CANCER; BREAST CANCER; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL LINE; CELL TYPE; COLON CANCER; CONTROLLED STUDY; CYTOGENETICS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; METAPHASE; MITOSIS INHIBITION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN CONTENT;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARRIER PROTEINS; CELL CYCLE; CELL DIVISION; CELL LINE; COLONIC NEOPLASMS; ESTRAMUSTINE; FEMALE; FLOW CYTOMETRY; HUMANS; KINETICS; MALE; METAPHASE; PROSTATIC NEOPLASMS; PROSTATIC SECRETORY PROTEINS; S PHASE; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0029760495     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hartley-Asp B: Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines DU-145 and PC-3. Prostate 5: 93-100, 1984.
2. Stearns ME, Tew KD: Antimicrotubule effect of esramustine, an antiprostatic tumor drug. Cancer Res 45: 3891-3897, 1985.
3. Stearns ME and Tew KD: Estramustine binds MAP-2 to inhibit microtubule assembly in vitro. J Cell Science 89: 331-342, 1988.
4. Kanje M, Deinum J, Wallin M, Ekström P, Edström A, Hartley-Asp B: Effect of estramustine phosphate on the assembly of isolated bovine brain microtubules and fast axonal transport in the frog sciatic nerv. Cancer Res 4: 2234-2239, 1985.
5. Wallin M, Deinum J, Hartley-Asp B: Estramustine phosphate inhibits microtubule assembly by binding to the microtubule-associated proteins. Ann NY Acad Sci 466: 423-425, 1986.
6. Stearns ME, Wang M, Tew KD, and Binder LI: Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupts microtubule organisation in DU 145 cells. J Cell Biol 107: 2647-2656, 1988.
7. Dahllöf B, Billström A, Cabral F, Hartley-Asp B: Estramustine depolymerizes microtubules by binding to tubulin. Cancer Res 53: 4573-4581, 1993.
8. Sheridan VR, Speicher LA, Tew KD: The effects of estramustine on metaphase and anaphase in DU 145 prostatic carcinoma cells. Eur J Cell Biol 54: 268-276, 1991.
9. Forsgren B, Gustafsson J-Å, Pousette Å, Högberg B: Binding characteristics of a major protein in rat ventral prostate cytosol that interacts with estramustine: a nitrogen mustard derivative of 17(b)-estradiol. Cancer Res 39: 5155-5164, 1979.
10. Forsgren B, Björk P, Carlstrîm K,Gustafsson J-Å, Pousette Å, Högberg B: Purification and distribution of a major protein in rat prostate that binds estramustine, a nitrogen mustard derivative of estradiol-17b. Proc Natl Acad Sci 76: 3149-3153, 1979.
11. Björk P, Fritjofsson Å and Hartley-Asp B: Uptake and binding of estramustine and estromustine, metabolites of estramustine phosphate (Estracyt), in the human prostate, and new aspects on the cytotoxic activity of estramustine phosphate in vitro. In: Experimentelle Urologie (Harzmann R et al eds), Springer-Verlag, Berlin, Heidelberg, 1985; pp 341-353.
12. Gunnarsson PO, Andersson S-B, Johansson S-Å, Nilsson T, Plym-Forshell G: Pharmacokinatics of estramustine phosphate (EstracytR) in prostatic cancer patients. Eur J Clin Pharmacol 26: 113-119, 1984.
13. Bergh J, Björk P, Westlin J-E and Nilsson S: Expression of an estramustine-binding associated protein in human lung cancer cell lines. Cancer Res 48: 4615-4619, 1988.
14. Björk P, Borg Å, Fernö M and Nilsson S: Expression and partial characterization of estramustine-binding protein (EMBP) in human breast cancer and malignant melanoma. Anticancer Res 11: 1173-1182, 1991.
15. von Schultz E, Carlström K, Henriksson R, Lagerlöf B, Hansson J: Estramustine binding protein in primary tumours and metastases of malignant melanoma. Melanoma Res 4(6): 401-405, 1994.
16. Björk P, Jönsson U, Andrén-Sandberg Å: Binding sites for the cytotoxic metabolites of the estramustine phosphate (Estracyt) in rat and human pancreas that are distinct from pancreatic estrogen-binding protein. Pancreas 6: 77-89, 1991.
17. von Schultz E, Bergenheim T, Grankvist K, Henriksson R: Estramustine binding protein in human brain tumor tissue. J Neurosurg 74: 962-964, 1991.
18. Bergenheim AT, Hartman M, Bergh J, Ridderheim PA, Henriksson R: Expression of estramustine-binding protein in ependymomas and in human and developing rat ependymal cells. J Neuro oncol 22(1): 45-53, 1994.
19. Tew KD: The mechanism of action of estramustine. Sem Oncol 10: 21-26, 1983.
20. Eklöv S, Larson A, Björk P, Nilsson S: The expression of estramustine-binding protein in the human prostatic cancer cell line DU 145 is not androgen dependent. Scand J Urol Nephrol 26: 119-125, 1992.
21. Fluchter SH, Nelde HJ, Björk P, Muntzing J and Bichler K-H: Effect of treatment on the expression of estramustine-binding protein (EMBP) in prostatic cancer patients: An immunohistochemical study. Prostate 14: 27-43, 1989.
22. Dustin P: Microtubules, Springer Verlag Berlin Heidelberg Tokyo 1984.
23. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulsson DF: Isolation of a human prostate carcinoma cell line (DU-145). Int J Cancer 21: 274-281, 1978.
24. Cailleau R, Young R, Olivé M, Reeves WJ: Breast tumor cell lines from pleural effusions. J Nat Can Inst Vol 53 3: 661-674, 1974.
25. Rigby CC, Franks LM: A human tissue culture cell line from a transitional cell tumour of the urinary bladder: growth, chromosome pattern and ultrastructure. Br J Cancer Vol XXIV 4: 746-754, 1970.
26. Busch C and Vasko J: Differential staining of mitosis in tissue sections and cultured cells by a modified methenamine-silver method. Lab Invest 59: 876-878, 1988.
27. Vindelöv LL, Christensen IbJ, Nissen NI: A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323-327, 1983.
28. Ryu S, Gabel M, Khil MS, Lee Yj, Kim SH, Kim JH: Estramustine: A novel radiation enhancer in human carcinoma cells. Int J Rad One Biol Phys Vol 30 1: 99-104, 1994.
29. Himes RH, Kersey RN, Heller-Bettinger I and Samson FE: Action of vinca alkaloids vincristine, vinblastine and desacetyl vinblastine amide on microtubules in vitro. Cancer Res 36: 3798-3802, 1976.
30. Norlén BJ, Andersson S-B, Björk P, Gunnarsson PO and Fritjofsson, Å: Uptake of estramustine phosphate (Estracyt) metabolites in prostatic cancer. J Urol 140: 1058-1062, 1988.
31. Eklöv S, Essand M, Carlsson J and Nilsson S: Radiation sensitization by estramustine, studies on cultured human prostatic cancer cells. Prostate 1992.